Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1377037 | 0.88 | HSD17B10 (0.39) | ALDH1A1TSHRBCHEACHEMEN1 | |
| SCHEMBL1374576 | 0.84 | TSHR (0.42) | ALDH1A1TSHRTHRBMEN1KMT2A | |
| SCHEMBL1376546 | 0.83 | CES2 (0.43) | TSHRTHRBMEN1KMT2AEPHX2 | |
| SCHEMBL1373872 | 0.81 | CES2 (0.46) | TSHRTHRBMEN1KMT2AEPHX2 | |
| SCHEMBL16467068 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBTHRA | |
| SCHEMBL1376572 | 0.80 | ALDH1A1 (0.36) | ALDH1A1TSHRBCHEACHEMEN1 | |
| SCHEMBL16467162 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRBCHEACHETHRB | |
| SCHEMBL1374476 | 0.78 | ALDH1A1 (0.35) | ALDH1A1TSHRBCHEACHEMEN1 | |
| SCHEMBL1374428 | 0.78 | BCHE (0.33) | ALDH1A1BCHEACHEMEN1KMT2A | |
| SCHEMBL2035630 | 0.77 | CES2 (0.41) | ALDH1A1TSHRSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674515-A1 | POLYMER SOLUTIONS FOR THE PREPARATION OF POLYMER MEMBRANES | Elantas GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4675689-A1 | COMPOSITION FOR USE IN MANUFACTURING OF BATTERIES | Elantas GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| EP-2837619-A1 | METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE | Idemitsu Kosan Co., Ltd (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8563495-B2 | Resist remover composition and method for removing resist using same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20110287995-A1 | RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | HACL2, APEH, NAAA | ALDH1A1 448/4885TSHR 1284/4885BCHE 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.